These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16310251)

  • 21. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
    Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
    Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells.
    Pasqualucci L; Kitaura Y; Gu H; Dalla-Favera R
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):395-400. PubMed ID: 16387847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line.
    Faili A; Aoufouchi S; Guéranger Q; Zober C; Léon A; Bertocci B; Weill JC; Reynaud CA
    Nat Immunol; 2002 Sep; 3(9):815-21. PubMed ID: 12145648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible switching of immunoglobulin hypermutation machinery in a chicken B cell line.
    Kanayama N; Todo K; Reth M; Ohmori H
    Biochem Biophys Res Commun; 2005 Feb; 327(1):70-5. PubMed ID: 15629431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of AID-mediated sequence diversification by cis-acting determinants.
    Yang SY; Schatz DG
    Adv Immunol; 2007; 94():109-25. PubMed ID: 17560273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the immunoglobulin locus specificity of hypermutation.
    Batrak V; Blagodatski A; Buerstedde JM
    Methods Mol Biol; 2011; 745():311-26. PubMed ID: 21660702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic mutations and activation-induced cytidine deaminase (AID) expression in established rheumatoid factor-producing lymphoblastoid cell line.
    Gil Y; Levy-Nabot S; Steinitz M; Laskov R
    Mol Immunol; 2007 Jan; 44(4):494-505. PubMed ID: 16574227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.
    Jain A; Ma CA; Lopez-Granados E; Means G; Brady W; Orange JS; Liu S; Holland S; Derry JM
    J Clin Invest; 2004 Dec; 114(11):1593-602. PubMed ID: 15578091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cytidine deaminase AID exhibits similar functional properties in yeast and mammals.
    Rogozin IB; Pavlov YI
    Mol Immunol; 2006 Mar; 43(9):1481-4. PubMed ID: 16219354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation-induced cytidine deaminase induces DNA break repair events more frequently in the Ig switch region than other sites in the mammalian genome.
    Lee SA; Parsa JY; Martin A; Baker MD
    Eur J Immunol; 2007 Dec; 37(12):3529-39. PubMed ID: 18034427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The recruitment of activation induced cytidine deaminase to the immunoglobulin locus by a regulatory element.
    Kim Y; Tian M
    Mol Immunol; 2010 May; 47(9):1860-5. PubMed ID: 20334924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of activation-induced cytidine deaminase (AID) in Burkitt lymphoma cells: rare AID-negative cell lines with the unmutated rearranged VH gene.
    Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Saigo K; Kawano S; Kumagai S; Nakamura F; Matsuo Y
    Leuk Lymphoma; 2004 Jan; 45(1):155-60. PubMed ID: 15061213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone inhibits activation-induced deaminase by binding to the promoter.
    Pauklin S; Petersen-Mahrt SK
    J Immunol; 2009 Jul; 183(2):1238-44. PubMed ID: 19553525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mismatch repair protein Msh6 influences the in vivo AID targeting to the Ig locus.
    Li Z; Zhao C; Iglesias-Ussel MD; Polonskaya Z; Zhuang M; Yang G; Luo Z; Edelmann W; Scharff MD
    Immunity; 2006 Apr; 24(4):393-403. PubMed ID: 16618598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL.
    Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Saigo K; Nakamachi Y; Kumagai S; Ohno H; Tanabe S; Uchida M; Yasuda N
    Leukemia; 2004 Apr; 18(4):826-31. PubMed ID: 14990977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional control of activation-induced cytidine deaminase and error-prone DNA polymerases is functionally mature in the B cells of infants at birth.
    Bowen AL; Tian C; LaFleur BJ; Crowe JE
    Hum Immunol; 2006; 67(1-2):43-6. PubMed ID: 16698424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.
    Tarsalainen A; Maman Y; Meng FL; Kyläniemi MK; Soikkeli A; Budzyńska P; McDonald JJ; Šenigl F; Alt FW; Schatz DG; Alinikula J
    J Immunol; 2022 Jan; 208(1):143-154. PubMed ID: 34862258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
    McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
    J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.